Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme

Nucleic Acids Research

Volumn 29, Issue 24, 2001, Pages 5071-5078

  Trang, Phong ^a   Lee, Jarone ^a   Kilani, Ahmed F ^a   Kim, Joe ^a   Liu, Fenyong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME VARIANT; RIBONUCLEASE P; RIBOZYME; VIRUS MESSENGER RNA;

ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ISOLATION; FEASIBILITY STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ENGINEERING; HERPES SIMPLEX VIRUS 1; IN VITRO SELECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA CLEAVAGE; RNA SEQUENCE; TRANSCRIPTION INITIATION; VIRUS INHIBITION; WILD TYPE;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0035945264     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.24.5071     Document Type: Article

References (55)

1. Herpes simplex viruses and their replication
2. Herpes simplex viruses
3. A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo
4. Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors
5. Group II introns designed to insert into therapeutically relevant DNA target sites in human cells
6. Antisense catalytic RNAs as therapeutic agents
7. Antiviral and anticancer ribozymes
8. Ribozymes, genomics and therapeutics
9. Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus
10. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1
11. Ribozymes as potential anti-HIV-1 therapeutic agents
12. Oncogene inactivation in a mouse model
13. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA
14. Ribonuclease P: Unity and diversity in a tRNA processing ribozyme
15. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme
16. External guide sequences for an RNA enzyme
17. Model substrates for an RNA enzyme
18. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: A novel approach for cancer treatment
19. Rational design of self-cleaving pre-tRNA-Ribonuclease P RNA conjugates
20. Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli
21. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli
22. Differential effects of the protein cofactor on the interactions between a RNase P ribozyme and its target mRNA substrate
23. UV crosslink mapping of the substrate binding site of RNase P ribozyme to a target mRNA sequence
24. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture
25. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate
26. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1
27. The protein cofactor allows the sequence of an RNase P ribozyme to diversify by maintaining the catalytically active structure of the enzyme
28. Kinetics of intermolecular cleavage by hammerhead ribozymes
29. Direct measurement of oligonucleotide substrate binding to wild-type and mutant ribozymes from Tetrahymena
30. Characterization of the protease and other products of amino-terminus-proximal cleavage of the herpes simplex virus 1 UL26 protein
31. Improved retroviral vectors for gene transfer and expression
32. Analysis of the structure of Tetrahymena nuclear RNAs in vivo: Telomerase RNA, the self-splicing rRNA intron and U2 snRNA
33. Lethal and temperature-sensitive mutations and their suppressors identify an essential structural element in U2 small nuclear RNA
34. The genomes of the human herpesviruses: Contents, relationships and evolution
35. Requirements for cleavage by a modified RNase P of a small model substrate
36. Different cleavage sites are aligned differently in the active site of M1 RNA, the catalytic subunit of Escherichia coli RNase P
37. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization
38. Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III
39. Targeted cleavage of mRNA by human RNase P
40. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
41. Expression of small, therapeutic RNAs in human cell nuclei
42. Inhibition of viral gene expression by human ribonuclease P
43. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4
44. Nucleic acid enzymes: Playing with a fuller deck
45. In vitro genetics
46. Directed molecular evolution
47. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA
48. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection
49. AUA-cleaving hammerhead ribozymes: Attempted selection for improved cleavage
50. In vitro genetic analysis of the Tetrahymena self-splicing intron
51. In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions
52. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma